Morhea Technologies, which develops electronic/electric signal generation technologies and applied approaches for the medical, governmental, and consumer electronics industries, is led by Richard Sorgnard. Multiple firms in the medical field are presently using Richard Sorgnard's unique technology (under a Morhea license).
Richard Sorgnard earned a Bachelor's and Master's Degree in Biology from Northwest Missouri State University after serving in the United States Air Force. Richard Sorgnard continued his education by earning a Ph.D. in Molecular Cell Biology from Northwestern University. Richard Sorgnard works in the medical, governmental, and consumer electronics industries on the design, development, engineering, and production of complicated electronic equipment, electric signal generation (EST) devices (including FHSS signaling), and applied methodologies.
Richard Sorgnard also works as the Director of Technology at the International Institute for Chronic Disease, where he develops clinical trial technology and protocols for a variety of chronic diseases.
